The Hematologist

banner image

2016 Meeting on Hematologic Malignancies

Co-chairs Drs. Ken Anderson and Martin Tallman encourage attending this year's meeting to learn about clinical updates in the field of malignant hematology.

Learn more
banner image

Ask the Hematologist Compendium

A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.

Learn more
banner image

Genomic Classification and Prognosis in AML

Dr. Moss looks at updates regarding the genomic classification of and treatment approaches to AML.

Read more
Current Issue Static Feature

Current Issue

July/August 2016              
Volume 13, Issue 4

Read current issue

President's Column

Dr Charles Abrams - new designProfessor of Medicine, Pathology, and Laboratory Medicine; Director PENN-CHOP Blood Center for Patient Care and Discovery, Philadelphia, PA
Open Borders Open MindsJune 23, 2016

Dr. Charles Abrams talks about the ASH executive committee's experience in Havana, Cuba during this year's retreat.

View all president's column articles

  • NHLBI’s Strategic Vision Reflects ASH’s Research Priorities
    August 18, 2016

    The National Heart Lung and Blood Institute (NHLBI) has released its strategic vision which highlights the goals and research priorities that will inform its policy and funding decisions for heart, lung, blood, and sleep diseases (HLBS) in the next several years. ASH participated in the NHLBI’s strategic visioning process and submitted additional comments when the NHLBI’s draft strategic priorities were released.

  • Medicare’s Inpatient Proposed Rule and What it Means for Hematology
    April 21, 2016

    The Centers for Medicare and Medicaid Services (CMS) released the annual set of proposals governing payments for services provided to patients admitted to the hospital, commonly referred to as the hospital inpatient prospective payment system (IPPS). ASH explores how this will affect hematologists.

  • ASH Pleads for Payment Innovation in Rare Diseases Such As Sickle Cell Disease
    April 12, 2016

    As part of the American Society of Hematology’s (ASH) multifaceted initiative to address the burden of sickle cell disease, ASH is in the process of working with stakeholders to improve access to care for individuals with sickle cell disease.  Included in this effort is

  • Medicare Proposes Radical Experiment in Drug Payment Policy
    March 10, 2016

    On March 8, 2016, the Center for Medicare and Medicaid Services (CMS) proposed a new experiment in payment rates for physician-administered drugs such as chemotherapy. This plan would change the current formula for drug payment so that payments for expensive drugs are reduced in certain areas of the country. In a second phase, CMS would be able to adopt certain tools to further adjust pricing for drugs.

View all Policy News